Showing 1 - 7 results of 7 for search 'Sanjeev Roy', query time: 0.03s
Refine Results
-
1
P102 Safety evaluation from an ongoing randomized, double-blind, multiple-ascending dose phase Ib study of enpatoran versus placebo in patients with active systemic or cutaneous lu... by Torsten Witte, Sanjeev Roy, Joerg Wenzel, Nadezda Abramova, Dominika Weinelt, Deborah Denis
Published 2024-03-01Article -
2
-
3
Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a analysis by Jens Kuhle, David Leppert, Giancarlo Comi, Nicola de Stefano, Ludwig Kappos, Mark S. Freedman, Andrea Seitzinger, Sanjeev Roy
Published 2024-03-01
Article -
4
P71 Treatment patterns, healthcare resource utilization and related costs of patients with discoid lupus erythematosus (DLE) or subacute cutaneous lupus erythematosus (SCLE) in the... by Ying Sun, Benjamin F Chong, Caroline Foch, Sanjeev Roy, Dominika Weinelt, Sabrina de Souza, Xiaoxue Chen, Jeffrey M Muir
Published 2024-03-01Article -
5
Model‐based meta‐analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus by Kosalaram Goteti, Ramon Garcia, William R. Gillespie, Jonathan French, Lena Klopp‐Schulze, Ying Li, Cristina Vazquez Mateo, Sanjeev Roy, Oliver Guenther, Lisa Benincosa, Karthik Venkatakrishnan
Published 2024-02-01
Article -
6
LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW) by Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson
Published 2023-07-01Article -
7
Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial by John E. McKinnon, Joel Santiaguel, Claudia Murta de Oliveira, Dongzi Yu, Mukhy Khursheed, Flavie Moreau, Lena Klopp‐Schulze, Jamie Shaw, Sanjeev Roy, Amy H. Kao, the ANEMONE Study Team
Published 2023-12-01
Article